Diabetes News Hound

The Food and Drug Administration (FDA) has warned DexCom, maker of blood sugar monitoring equipment that require inserting wires in the abdomen, that it is not adequately warning users that its devices sometimes leave wire splinters under the skin of some users (more…)

Researchers at the Mayo Clinic say they have found a way to keep insulin acting in the body longer, potentially opening the gates for new treatments for diabetes (more…)

MannKind, the maker of a new, more potent form of inhalable insulin, says clinical data shows the product is safe to the lungs (more…)

The FDA is thinking about curbing a trial that compares controversial Type 2 diabetes drug Avandia with Actos, another drug in the same class (more…)

Acclaimed Broadway actor Ben Vereen is “taking a stand” against Type 2 diabetes (more…)

Researchers say that Salsalate, a generic aspiring-like drug, has proven effective at helping Type 2 diabetic patients lower their blood sugar levels during a small human trial (more…)

Dallas-based Access Pharmaceuticals said that it will begin testing a new oral insulin drug in humans (more…)

The controversial Type 2 diabetes drug Avandia from GlaxoSmithKline has been linked to more than 1,000 deaths between January and September 2009, according to a recent analysis from the non-profit Institute for Safe Medication Practices. (more…)

Medtronic, one of the leaders in insulin pump technology, gained FDA approval for its Revel technology earlier this month. It’s a step closer to the “artificial pancreas,” which many are calling the holy grail for Type 1 diabetics (more…)